SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : momo-T/FIF

 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: tuck who wrote (2934)8/25/2005 10:44:56 PM
From: scaram(o)uche  Read Replies (2) of 12215
 
Your question brought out fun commentary. Thanks.

Polymorphism within the MHC is extreme. I was lucky as heck. For decades, the lab of George Snell and numerous other labs which recognized the brilliance in his approach had focused on dissecting the MHC with polyclonal antisera.

It was a rush to isolate antibodies which recognized an epitope that Snell et al. (in the very large sense, as he cast a long shadow........ a frigging gentleman and unassuming guy, I might add) had characterized with a titer of 1:20 or sumthin (and they busted their butt to get that!), and find that you could ten-fold dilute seven times before starting your assay.

It was a bigger rush to discover that one out of two antibodies found something that a score of the best had missed for years.

Antibodies are fun. Wholesome, good for the entire family.

I'm moving, folks. Gonna be spotty in the next week.

Small-cap, big-science....... great summer. Phenomenal summer. Heaven.

Best, all!

Rick
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext